Edition:
United States

Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

153.77USD
24 Mar 2017
Change (% chg)

$-0.88 (-0.57%)
Prev Close
$154.65
Open
$154.43
Day's High
$155.67
Day's Low
$153.69
Volume
1,289,143
Avg. Vol
1,881,731
52-wk High
$161.66
52-wk Low
$137.40

TMO

Chart for TMO

About

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical... (more)

Overall

Beta: 1.11
Market Cap(Mil.): $60,373.98
Shares Outstanding(Mil.): 390.39
Dividend: 0.15
Yield (%): 0.39

Financials

  TMO Industry Sector
P/E (TTM): 30.34 47.70 29.72
EPS (TTM): 5.10 -- --
ROI: 5.21 6.90 13.00
ROE: 9.44 10.89 14.15

BRIEF-Thermo Fisher Scientific and Cell And Gene Therapy Catapult collaborate

* Thermo Fisher Scientific Inc - co and Cell And Gene Therapy Catapult collaborate to optimise advanced therapy supply chain Source text for Eikon: Further company coverage:

Mar 21 2017

BRIEF-Thermo Fisher issues 500 mln euro of certain senior notes due 2027

* On March 16, 2017, issued EUR 500 million aggregate principal amount of 1.450 pct senior notes due 2027

Mar 16 2017

Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision.

Feb 22 2017

Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision.

Feb 22 2017

UPDATE 2-Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

Feb 22 The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision.

Feb 22 2017

Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

Feb 22 The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court's decision.

Feb 22 2017

BRIEF-Asuragen enters into collaboration deal with Thermo Fisher

* Asuragen Inc - Entered collaboration deal with Thermo Fisher scientific for development, commercialization of capillary electrophoresis-based in vitro diagnostics Source text for Eikon: Further company coverage:

Feb 20 2017

BRIEF-Thermo Fisher Scientific receives early termination of Hart-Scott-Rodino waiting period for acquisition of Finesse Solutions

* Thermo Fisher Scientific receives early termination of Hart-Scott-Rodino waiting period for acquisition of Finesse Solutions Inc

Feb 13 2017

BRIEF-Thermo Fisher Scientific sees FY'17 adj EPS bewteen $9.06 - $9.24 - Conf call

* Thermo Fisher Scientific Inc sees FY 2017 revenue between $19.38 billion to $19.62 billion - Conf call

Jan 31 2017

BRIEF-Thermo Fisher Scientific reports Q4 GAAP EPS of $1.59

* Q4 Life Sciences Solutions segment revenue grew 10 percent to $1.34 billion Source text for Eikon: Further company coverage:

Jan 31 2017

More From Around the Web

Earnings vs. Estimates